Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration

Retina

Volumn 27, Issue 7, 2007, Pages 879-890

  Parisi, Vincenzo ^a   Perillo, Loredana ^a   Tedeschi, Massimiliano ^a   Scassa, Cecilia ^a   Gallinaro, Geltrude ^a   Capaldo, Nicoletta ^a   Varano, Monica ^a  

^a IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

AMD; mfERG; Microperimetry

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOPHYSIOLOGY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; SLIT LAMP; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; PERIMETRY; PSYCHOPHYSIOLOGY; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 34748851309     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318042d6aa     Document Type: Article

References (57)

1. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study I: outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
2. Klein R, Klein BEK, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2002;109:1767-1779.
3. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003;121:519-526.
4. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 2003;121:658-663.
5. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999;117:1203-1210.
6. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficult in daily life. Ophthalmology 2002;109:1235-1242.
7. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-191.
8. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study. Surv Ophthalmol 1995;39:367-374.
9. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436.
10. Bressler SB, Maguire MG, Bressler NM, Fine SL. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 1990;108:1442-1447.
11. Burgess DB, Hawkins BS, Jefferys J, et al. Macular Photocoagulation Study Group: five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993;111:1189-1199.
12. Maguire MG, Bressler SB, Bressler NM, et al. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1997;115:741-747.
13. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994;101:1522-1528.
14. Springer C, Bultmann S, Volcker HE, Rohrschneider K. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology 2005;112:848-854.
15. Varano M, Parisi V, Tedeschi M, et al. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation. Invest Ophthalmol Vis Sci 2005;46:1453-1462.
16. Parisi V, Falsini B. Electrophysiological evaluation of the macular cone system: focal electroretinography and visual evoked potentials after photostress. Semin Ophthalmol 1998;13:178-188.
17. Seiple WH, Siegel IM, Carr RE, Mayron C. Evaluating macular function using the focal ERG. Invest Ophthalmol Vis Sci 1986;27:1123-1130.
18. Iarossi G, Falsini B, Piccardi M. Regional cone dysfunction in retinitis pigmentosa evaluated by flicker ERGs: relationship with perimetric sensitivity losses. Invest Ophthalmol Vis Sci 2003;44:866-874.
19. Parisi V, Canu D, Iarossi G, et al. Altered recovery of macular function after bleaching in Stargardt's disease-fundus flavimaculatus: pattern VEP evidence. Invest Ophthalmol Vis Sci 2002;43:2741-2748.
20. Hood D. Evaluating local retinal function by the multifocal techniques. Prog Retin Eye Res 2000;19:607-646.
21. Gerth C, Delahunt PB, Alam S, Morse LS, Werner JS. Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up. Arch Ophthalmol 2006;12:345-352.
22. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1991;32:8-20.
23. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 1992;33:334-340.
24. Eisner A, Klein ML, Zilis JD, Watkins MD. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1992;33:3091-3102.
25. Midena E, Segato T, Blarzino MC, Degli Angeli C. Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol 1994;88:179-185.
26. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 1997;38:469-477.
27. Sandberg MA, Miller S, Gaudio AR. Foveal cone ERGs in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 1993;34:3477-3480.
28. Falsini B, Fadda A, Iarossi G, et al. Retinal sensitivity to flicker modulation: reduced by early age-related maculopathy. Invest Ophthalmol Vis Sci 2000;41:1498-1506.
29. Falsini B, Serrao S, Fadda A, et al. Focal electroretinograms and fundus appearance in nonexudative age-related macular degeneration. Quantitative relationship between retinal morphology and function. Graefes Arch Clin Exp Ophthalmol 1999;237:193-200.
30. Scullica L, Falsini B. Diagnosis and classification of macular degenerations: an approach based on retinal function testing. Doc Ophthalmol 2001;102:237-250.
31. Falsini B, Piccardi M, Iarossi G, et al. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology 2003;110:51-60.
32. Jackson GR, McGwin G Jr, Phillips JM, Klein R, Owsley C. Impact of aging and age-related maculopathy on activation of the a-wave of the rod-mediated electroretinogram. Invest Ophthalmol Vis Sci 2004;45:3271-3278.
33. Huang S, Wu D, Jiang F, et al. The multifocal electroretinogram in age-related maculopathies. Doc Ophthalmol 2000;101:115-124.
34. Li J, Tso MO, Lam TT. Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol 2001;85:287-290.
35. Heinemann-Vernaleken B, Palmowski AM, Allgayer R, Ruprecht KW. Comparison of different high resolution multifocal electroretinogram recordings in patients with age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 2001;239:556-561.
36. Chen C, Wu L, Wu D, et al. The local cone and rod system function in early age-related macular degeneration. Doc Ophthalmol 2004;109:1-8.
37. Feigl B, Lovie-Kitchin J, Brown B. Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram. Clin Exp Optom 2005;88:304-312.
38. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-1134.
39. Scholl HP, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci 2004;45:574-583.
40. Hood DC, Frishman LJ, Saszik S, Viswanathan S. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 2002;43:1673-1685.
41. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257-293.
42. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988;2:552-577.
43. Bok D. Retinal photoreceptor-pigment epithelium interactions: Friedenwald lecture. Invest Ophthalmol Vis Sci 1985;26:1659-1694.
44. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31:291-306.
45. Schmitz-Valckenberg S, Bultmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004;45:4470-4476.
46. Green WR, Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman lecture. Ophthalmology 1993;100:1519-1535.
47. Green WR. Histopathology of age-related macular degeneration. Mol Vis 1999;5:27.
48. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci 2003;44:4481-4488.
49. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1236-1249.
50. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20:705-732.
51. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001;20:385-414.
52. Remulla JF, Gaudio AR, Miller S, Sandberg MA. Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Br J Ophthalmol 1995;79:558-561.
53. Frennesson C, Nilsson UL, Nilsson SE. Colour contrast sensitivity in patients with soft drusen, an early stage of ARM. Doc Ophthalmol 1995;90:377-386.
54. Stangos N, Voutas S, Topouzis F, Karampatakis V. Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity. Ophthalmologica 1995;209:194-198.
55. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology 2001;108:1196-1202.
56. Frisen L, Frisen M. Micropsia and visual acuity in macular edema: a study of the neuro-retinal basis of visual acuity. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1979;2:69-77.
57. Sunness JS, Massof RW, Johnson MA, Bressler NM, Bressler SB, Fine SL. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmology 1989;96:375-381.